Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 71 | 56 | 10,305 | 1,709 | 53,409 |
| Gross Profit | 71 | 56 | 10,305 | 1,709 | 53,409 |
| Operating Expenses | 13,644 | 14,030 | 9,642 | 10,403 | 11,719 |
| Operating Income | -13,573 | -13,974 | 663 | -8,694 | 41,690 |
| Interest Expense | 0 | 0 | 0 | 58 | 103 |
| Other Income | 132 | 94 | 44 | 37 | 26 |
| Pre-tax Income | -13,441 | -13,880 | 707 | -8,715 | 41,613 |
| Income Tax | N/A | N/A | 23 | -161 | 567 |
| Net Income Continuous | -13,441 | -13,880 | 684 | -8,554 | 41,046 |
| Net Income | $-13,441 | $-13,880 | $684 | $-8,554 | $41,046 |
| EPS Basic Total Ops | -0.60 | -0.63 | 0.12 | -0.39 | 1.89 |
| EPS Basic Continuous Ops | -0.61 | -0.63 | 0.13 | -0.39 | 1.89 |
| EPS Diluted Total Ops | -0.60 | -0.63 | 0.16 | -0.39 | 1.80 |
| EPS Diluted Continuous Ops | -0.61 | -0.63 | 0.16 | -0.39 | 1.80 |
| EBITDA(a) | $-13,300 | $-13,708 | $956 | $-8,366 | $42,042 |